Restoring cortical control of functional movement in a human with quadriplegia.
Chad E Bouton, Ammar Shaikhouni, Nicholas V Annetta...
https://pubmed.ncbi.nlm.nih.gov/27074513/Actively Recruiting
Led by Northwell Health · Updated on 2026-03-11
64
Participants Needed
1
Research Sites
26 weeks
Total Duration
Researchers are evaluating whether transcutaneous neuromuscular electrical stimulation, with or without transcutaneous spinal cord stimulation, using an investigational neurostimulation device can improve arm and hand movements in people with paralysis or weakness caused by spinal cord injury, stroke, or other brain or nerve injuries. This early feasibility trial aims to study functional improvements in both upper and lower limbs depending on the type of injury. Participants will attend up to 5 study sessions per week for up to one year, with each session lasting as long as 4 hours. During sessions, the study team will manually map and then deliver electrical stimulation to muscles andor the spinal column to evoke specific limb movements. Electroconductive gels or hydrogels will be used to assist electrode placement. The study includes four groups healthy volunteers and individuals with spinal cord injury, stroke, or other brain or nerve injuries, all receiving stimulation targeted to improve movement. At the first session, demographic information and vital signs will be collected, along with baseline clinical evaluations of movement and sensation. Throughout the study, participants will perform tasks designed to improve movement, with assessments using visual inspection, electromyography, motion tracking, and various validated clinical tests to measure functional changes. Participation ends after the last session when functional improvements are evaluated against baseline. The primary outcome is device feasibility for changing muscle activation over 12 months.
CONDITIONS
Chronic Transcutaneous Stimulation to Promote Motor Function and Recovery in Individuals With Paralysis or Paresis
E
Erona Ibroci, MPH
C
Chad E Bouton, MS
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Northwell Health
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Investigational: Transcutaneous Electrical Stimulation plus therapy | Active comparator: Healthy volunteers with stimulation | Contextual: Standard rehabilitation care |
|---|---|---|---|
| What it is | An investigational neurostimulator delivers transcutaneous electrical pulses combined with task‑based functional movement sessions for individuals with paralysis or paresis. | Healthy individuals undergo the same stimulation protocol to assess safety and feasibility of neurostimulation. | Typical rehabilitation for paralysis or paresis involves task‑specific training and therapy without electrical stimulation. |
| Role in the trial | Receives investigational stimulation plus functional therapy. | Serves as active comparator group to evaluate safety and device response in individuals without impairment. | Not part of trial; represents usual care context without stimulation. |
| Primary use | To explore feasibility of delivering transcutaneous stimulation to evoke functional movement and assess motor activation in paralysis or paresis. | To assess safety and motor activations in individuals without neurological impairment. | Provide functional movement through task‑specific rehabilitation without electrical neuromodulation. |
| How it is given or performed | Participants receive up to five sessions per week of functional task‑based practice combined with neurostimulator-delivered transcutaneous electrical pulses over muscles or spinal column. | Same stimulation protocol as investigational group but in individuals without impairment. | Task‑specific training delivered without neurostimulation. |
| Evidence status | Early feasibility data suggest motor function improvements (e.g., voluntary movement, strength, sensation) in small numbers, but formal efficacy remains unproven. | No serious adverse events reported in small feasibility cohorts receiving stimulation. | Task‑specific rehab without stimulation is a well‑established approach for improving motor function. |
| Important risks | Limited safety data; no serious events reported in small-scale trials, but broader risks remain undercharacterized. | No serious adverse events reported in healthy individuals during stimulation feasibility studies. | Standard rehabilitative therapy carries typical risks of physical exercise but no stimulation‑related safety concerns. |
| Important limitations | Findings are from small samples and non‑randomized design; controlled trials are needed to establish benefit reliably. | Healthy volunteer data do not reflect functional benefit in target patient populations. | Without stimulation, improvements may be slower or limited, but direct comparative gains relative to tSCS are not yet evidenced. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 12 months
Participants receive transcutaneous electrical stimulation to muscles and/or spinal column to evoke specific limb movements. Mapping sessions are conducted to determine optimal electrode placement using electroconductive gels and hydrogels. Functional movement is assessed through clinical tests and sensors.
Up to 5 sessions per week, each lasting up to 4 hours
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
DEVICE_FEASIBILITY
Number of Arms
4
Have more questions? Get in touch with our team for quick support
Chad E Bouton, Ammar Shaikhouni, Nicholas V Annetta...
https://pubmed.ncbi.nlm.nih.gov/27074513/Nikunj Bhagat, Kevin King, Richard Ramdeo...
https://pubmed.ncbi.nlm.nih.gov/32864392/John Ciancibello, Kevin King, Milad Alizadeh Meghrazi...
https://pubmed.ncbi.nlm.nih.gov/32232108/Northwell Health
Lead Sponsor